GENE ONLINE|News &
Opinion
Blog

Neurodegenerative Disease
M&A m&aBristol Myers SquibbKaruna TherapeuticsNeuroscience
Bristol Myers Squibb Acquires Karuna Therapeutics to Enhance Neuroscience Portfolio
2023-12-25
R&D ObesityNeurodegenerative Disease
New Research Links High-Sugar Diets and Obesity to Neurodegenerative Disorders
2023-11-14
Innovation Amyotrophic Lateral Sclerosis
Harvard’s Soft Robotic Wearable Device Helps ALS Patients Regain Arm Mobility
2023-02-09
Trials & Approvals Gene Therapy
Bluebird’s Rare Childhood Neurodegenerative Gene Therapy Gains Accelerated Approval
2022-09-19
R&D Huntington's Disease
Human Skin Cells Reprogramming Creates New Neurodegenerative Model For Huntington’s Disease
2022-08-31
Trials & Approvals ALS
Canada Approves Amylyx’s Experimental ALS Drug
2022-06-14
Funding Neurodegenerative Disease
NRG Therapeutics Wins £2.68M to Treat Chronic Neurodegenerative Disorders
2022-05-31
Funding Neurodegenerative Disease
Pfizer, Lilly-Backed Neuro Company Bags $64 Million Series B To Correct Progranulin Deficiency in Dementia
2022-02-11
Asia-Pacific Neurodegenerative Disease
Japan’s Ono Pharmaceutical Expands Collab with Neurimmune to Discover Antibodies for Neurodegenerative Disorders
2022-01-18
Deals Parkinson’s Disease
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Technology CRISPR
Novel CRISPR Screen Unravels Disease-Related Genes in Neurons
2021-05-31
R&D Neurodegenerative Disease
Takeda to Pursue Hard-to-Drug Neurodegenerative Disease Targets with BridGene Biosciences
2021-04-01
Trials & Approvals Autoimmune Disease
Janssen’s Multiple Sclerosis Drug Snags FDA Win after Besting Sanofi’s Blockbuster in Phase 3
2021-03-21
Trials & Approvals Alzheimer's Disease
Biohaven’s Troriluzole Joins Long List of Failed Alzheimer’s Drugs
2021-01-21
M&A SARM1
Eli Lilly Intends to Disarm Axonal Degeneration with Newest Acquisition
2020-10-17
1 2
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top